Old Web
English
Sign In
Acemap
>
authorDetail
>
Tim A. Brighton
Tim A. Brighton
Medicine
Cardiology
Internal medicine
Anticoagulant
Warfarin
3
Papers
252
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
2014
The Lancet Haematology
Martin H. Prins
Anthonie W. A. Lensing
Tim A. Brighton
Roger M. Lyons
Jeffrey Rehm
Mila Trajanovic
Bruce L. Davidson
Jan Beyer-Westendorf
Akos F. Pap
Scott D. Berkowitz
Alexander A. Cohen
Michael J. Kovacs
Philip S. Wells
Paolo Prandoni
Show All
Source
Cite
Save
Citations (195)
Ximelagatran: direct thrombin inhibitor.
2006
Vascular Health and Risk Management
Shir-Jing Ho
Tim A. Brighton
Show All
Source
Cite
Save
Citations (37)
Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patients
2004
Blood Coagulation & Fibrinolysis
Judy Craft
Paul P. Masci
Michael S. Roberts
Tim A. Brighton
P. Garrahy
Stephen Cox
Neville A. Marsh
Show All
Source
Cite
Save
Citations (20)
1